Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immuno-inflammatory Manifestations With or Without Clonal Hematopoiesis: Ambispective Cohort Study

NCT05969821 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT05969821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05969821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immuno-inflammatory Manifestations With or Without Clonal Hematopoiesis: Ambispective Cohort Study
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Observational
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
September 30, 2045
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diseases, autoinflammatory diseases, clonal hematopoiesis of indeterminate potential, hematologic diseases, hematopoiesis clonal, immune system diseases, inflammation, leukemia, leukemia myelomonocytic chronic, lymphoma, lymphoproliferative disorders, monoclonal gammopathy of undetermined significance, myelodysplastic syndromes, myelodysplastic-myeloproliferative diseases, myeloproliferative disorders, vexas syndrome